Investigation of skeletal muscle quantity and quality in end-stage renal disease - PubMed (original) (raw)
Randomized Controlled Trial
doi: 10.1111/j.1440-1797.2009.01261.x.
Haifa Abas, Benjamin Smith, Anthony J O'Sullivan, Maria Chan, Aditi Patwardhan, John Kelly, Adrian Gillin, Glen Pang, Brad Lloyd, Klaus Berger, Bernhard T Baune, Maria Fiatarone Singh
Affiliations
- PMID: 20609098
- DOI: 10.1111/j.1440-1797.2009.01261.x
Randomized Controlled Trial
Investigation of skeletal muscle quantity and quality in end-stage renal disease
Birinder Cheema et al. Nephrology (Carlton). 2010 Jun.
Abstract
Aim: A more precise understanding of the aetiology and sequelae of muscle wasting in end-stage renal disease (ESRD) is required for the development of effective interventions to target this pathology.
Methods: We investigated 49 patients with ESRD (62.6 +/- 14.2 years, 0.3-16.7 years on haemodialysis). Thigh muscle cross-sectional area (CSA), intramuscular lipid and intermuscular adipose tissue (IMAT) were measured via computed tomography as indices of muscle quantity (i.e. CSA) and quality (i.e. intramuscular lipid and IMAT). Additional health and clinical measures were investigated to determine associations with these variables.
Results: Age, energy intake, disease burden, pro-inflammatory cytokines, nutritional status, strength and functioning were related to muscle quantity and quality. Potential aetiological factors entered into forward stepwise regression models indicated that hypoalbuminaemia and lower body mass index accounted significantly and independently for 32% of the variance in muscle CSA (r = 0.56, P < 0.001), while older age and interleukin-8 accounted for 41% of the variance in intramuscular lipid (r = 0.64, P < 0.001) and body mass index accounted for 45% of the variance in IMAT (r = 0.67, P < 0.001). Stepwise regression models revealed that intramuscular lipid was independently predictive of habitual gait velocity and 6 min walk distance, while CSA was independently predictive of maximal isometric strength (P < 0.05).
Conclusion: Ageing, poor nutritional status and elevated interleukin-8 are factors potentially contributing to the loss of muscle quality and quantity in ESRD. These deficits can predict functional impairments, with intramuscular lipid accumulation most closely related to decline of submaximal musculoskeletal performance (walking), and low muscle CSA most closely related to decline of maximal performance (peak isometric strength).
Similar articles
- Muscle mass loss and intermuscular lipid accumulation were associated with insulin resistance in patients receiving hemodialysis.
Wang HL, Ding TT, Lu S, Xu Y, Tian J, Hu WF, Zhang JY. Wang HL, et al. Chin Med J (Engl). 2013;126(24):4612-7. Chin Med J (Engl). 2013. PMID: 24342298 - Patients receiving maintenance dialysis have more severe functionally significant skeletal muscle wasting than patients with dialysis-independent chronic kidney disease.
McIntyre CW, Selby NM, Sigrist M, Pearce LE, Mercer TH, Naish PF. McIntyre CW, et al. Nephrol Dial Transplant. 2006 Aug;21(8):2210-6. doi: 10.1093/ndt/gfl064. Epub 2006 Feb 27. Nephrol Dial Transplant. 2006. PMID: 16504974 - Preliminary evidence that low ankle-brachial index is associated with reduced bilateral hip extensor strength and functional mobility in peripheral arterial disease.
Parmenter BJ, Raymond J, Dinnen PJ, Lusby RJ, Fiatarone Singh MA. Parmenter BJ, et al. J Vasc Surg. 2013 Apr;57(4):963-973.e1. doi: 10.1016/j.jvs.2012.08.103. Epub 2012 Dec 14. J Vasc Surg. 2013. PMID: 23246081 Clinical Trial. - Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness.
Ryall JG, Schertzer JD, Lynch GS. Ryall JG, et al. Biogerontology. 2008 Aug;9(4):213-28. doi: 10.1007/s10522-008-9131-0. Epub 2008 Feb 26. Biogerontology. 2008. PMID: 18299960 Review. - [Muscle-wasting in end stage renal disease in dialysis treatment: a review].
Battaglia Y, Galeano D, Cojocaru E, Fiorini F, Forcellini S, Zanoli L, Storari A, Granata A. Battaglia Y, et al. G Ital Nefrol. 2016 Mar-Apr;33(2):gin/33.2.7. G Ital Nefrol. 2016. PMID: 27067216 Review. Italian.
Cited by
- Skeletal Muscle Injury in Chronic Kidney Disease-From Histologic Changes to Molecular Mechanisms and to Novel Therapies.
Heitman K, Alexander MS, Faul C. Heitman K, et al. Int J Mol Sci. 2024 May 8;25(10):5117. doi: 10.3390/ijms25105117. Int J Mol Sci. 2024. PMID: 38791164 Free PMC article. Review. - Intramuscular adipose tissue, muscle area, and power as predictors of performance in breast cancer survivors.
de Lima ML, de Oliveira AA, Carneiro MAS, Silva SHA, de Queiroz Freitas AC, de Souza LRMF, Nomelini RS, Souza MVC, de Oliveira Assumpção C, Orsatti FL. de Lima ML, et al. Support Care Cancer. 2024 May 24;32(6):380. doi: 10.1007/s00520-024-08595-z. Support Care Cancer. 2024. PMID: 38789606 - Myosteatosis and aortic calcium score on abdominal CT as prognostic markers in non-dialysis chronic kidney disease patients.
Kim A, Lee CM, Kang BK, Kim M, Choi JW. Kim A, et al. Sci Rep. 2024 Apr 2;14(1):7718. doi: 10.1038/s41598-024-58293-3. Sci Rep. 2024. PMID: 38565556 Free PMC article. - Making the invisible visible: imaging techniques for assessing muscle mass and muscle quality in chronic kidney disease.
Sabatino A, Sola KH, Brismar TB, Lindholm B, Stenvinkel P, Avesani CM. Sabatino A, et al. Clin Kidney J. 2024 Feb 20;17(3):sfae028. doi: 10.1093/ckj/sfae028. eCollection 2024 Mar. Clin Kidney J. 2024. PMID: 38444750 Free PMC article. Review. - Abdominal computed tomography measurements of body composition and waitlist mortality in kidney transplant candidates.
Quint EE, Liu Y, Shafaat O, Ghildayal N, Crosby H, Kamireddy A, Pol RA, Orandi BJ, Segev DL, Weiss CR, McAdams-DeMarco MA. Quint EE, et al. Am J Transplant. 2024 Apr;24(4):591-605. doi: 10.1016/j.ajt.2023.11.002. Epub 2023 Nov 8. Am J Transplant. 2024. PMID: 37949413
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical